ArticleDiabetology & metabolic syndrome2024

Simvastatin reduces chronic kidney disease and renal failure risk in type 2 diabetes patients: post hoc ACCORD trial analysis.

Jiaxi Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.